hongbin deng
Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences
Beijing, China
Associate Editor
Cancer Immunity and Immunotherapy
Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences
Beijing, China
Associate Editor
Cancer Immunity and Immunotherapy
Second University of Naples
Naples, Italy
Associate Editor
Cancer Immunity and Immunotherapy
Center for Immuno-Oncology/Siena University Hospital
Siena, Italy
Associate Editor
Cancer Immunity and Immunotherapy
National Cancer Institute Foundation (IRCCS)
Milan, Italy
Associate Editor
Cancer Immunity and Immunotherapy
City of Hope National Medical Center
Duarte, United States
Associate Editor
Cancer Immunity and Immunotherapy
Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz
Mainz, Germany
Associate Editor
Cancer Immunity and Immunotherapy
Uppsala University
Uppsala, Sweden
Associate Editor
Cancer Immunity and Immunotherapy
Peter MacCallum Cancer Centre
Melbourne, Australia
Associate Editor
Cancer Immunity and Immunotherapy
College of Medicine and Science, Mayo Clinic
Rochester, United States
Associate Editor
Cancer Immunity and Immunotherapy
The Ohio State University
Columbus, United States
Associate Editor
Cancer Immunity and Immunotherapy
Erasmus Medical Center
Rotterdam, Netherlands
Associate Editor
Cancer Immunity and Immunotherapy
Mayo Clinic
Rochester, United States
Associate Editor
Cancer Immunity and Immunotherapy
Tempest Therapeutics, Inc.
Brisbane, United States
Associate Editor
Cancer Immunity and Immunotherapy
University of Alabama at Birmingham
Birmingham, United States
Associate Editor
Cancer Immunity and Immunotherapy
Medical College of Wisconsin
Milwaukee, United States
Associate Editor
Cancer Immunity and Immunotherapy
Medical University of Vienna
Vienna, Austria
Associate Editor
Cancer Immunity and Immunotherapy